Zura Bio Ltd (ZURA) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-01-27

Key Insights

Parvinder Thiara, a director of Zura Bio Ltd, has acquired 38,823 stock options with an exercise price of $6.36 and a 10-year expiration date.
The options vest over a one-year period, with any remaining unvested portion vesting immediately prior to the next annual shareholder meeting, subject to Thiara's continued service.
This transaction represents a long-term bullish signal, as insiders often acquire stock options when they are optimistic about the company's future performance.

Want the newest filings?

This analysis covers the filing from 2026-01-27. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-23

Sandeep Kulkarni, the CEO of Zura Bio Ltd, acquired a significant equity stake of 2,934,107 Class A Ordinary Shares through a stock option grant, indicating his confidence in the company's future performance.
The option award vests over time, with one-fourth vesting in the first year and the remaining shares vesting in equal quarterly installments thereafter, aligning the CEO's interests with long-term shareholder value creation.
This transaction suggests the CEO's continued commitment to the company and alignment with shareholders, which could be viewed positively by investors.

Other reports for Zura Bio Ltd

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.